Učitavanje...
Clinical development of novel proteasome inhibitors for cancer treatment
BACKGROUND: Emerging evidence demonstrates that targeting the tumor proteasome is a promising strategy for cancer therapy. OBJECTIVE: This review summarizes recent results from cancer clinical trials using specific proteasome inhibitors or some natural compounds that have proteasome-inhibitory effec...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2009
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3758888/ https://ncbi.nlm.nih.gov/pubmed/19505187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543780903002074 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|